Name: 49th Preston Robb Neuroscience Day
Start: 2024-11-27T08:30:00+01:00
End: 2024-11-27T13:00:00+01:00
Location: RI Auditorium, Glen Site (MUHC)

The event honours the career and memory of Preston Robb, who is considered one of the founders of Canadian child neurology.
About this Event

The event will kick off with abstract presentations from 8:30 to 11:00 a.m., showcasing the latest research in neuroscience. A refreshment pause will follow from 11:00 to 11:50 a.m., providing an opportunity for networking and discussion. At 12:00 p.m., the Preston Robb Lecture will be held in the auditorium, featuring Dr. Jim Dowling (MD, PhD) as the keynote speaker.

Location: MUHC - Glen Site, E S1.1129 / auditorium of the Research Institute

Call for Abstracts: We invite you to submit abstracts on any neuroscience-related topic (up to 150 words). Please confirm your participation by submitting your abstract, including the title and author(s) of your presentation, by Friday, November 1, 2024. Submit your abstracts here: Abstract Submission - 49th Preston Robb Neuroscience Day (google.com)

Preston Robb Neuroscience Lecture (12:00 p.m. - 1:00 p.m.)

The Future Is Now: Therapy Development for Neurogenetic Diseases

Jim Dowling, MD, PhD

Senior Scientist, Genetics & Genome Biology, The Hospital for Sick Children

Professor, Departments of Paediatrics and Molecular Genetics, University of Toronto

Bio: Dr. James Dowling is a clinician-scientist focused on gene discovery and therapy development for childhood muscle diseases. He is a staff clinician and senior scientist at the Hospital for Sick Children and a Professor of Paediatrics and Molecular Genetics at the University of Toronto.

Dr. Dowling received his BSc and MSc from Yale University and his MD/PhD from the University of Chicago. His PhD work was performed in the laboratory of Elaine Fuchs. He did his residency in child neurology at Children’s Hospital of Philadelphia and completed postdoctoral research with Jeff Golden (UPenn) and Eva Feldman (University of Michigan). Before coming to Toronto, he was an assistant professor at the University of Michigan from 2009-2013.

Dr. Dowling’s clinical expertise is in childhood neuromuscular disorders. His research examines questions of disease pathogenesis and therapy development for congenital myopathies. In addition to his research program, he currently serves as chair of the executive board of TREAT NMD and is an executive board member of the World Muscle Society.